Drug Discovery

Precision medicine for COVID-19 pandemic

Katerina Boididou, MSc / 3 February 2021
Stem Cells

How to Characterize Stem Cells using Immunofluorescence (Immunocytochemistry)

Zara Puckrin, BSc / 29 January 2021
Stem Cells

StemFit® Mesenchymal Stem Cell therapy for liver cirrhosis [INTERVIEW]

Zara Puckrin, BSc / 4 January 2021
Drug Discovery

Understanding the Dapivirine Vaginal Ring for HIV prevention

Zara Puckrin, BSc / 15 December 2020
Stem Cells

Five reasons to choose StemRNA 3rd Gen Reprogramming Technology

Anca Haralambie, MSc / 4 December 2020
Drug Discovery

Predicting Psoriasis Drug Efficacy in Human Skin [INFOGRAPHIC]

Zara Puckrin, BSc / 17 September 2020

StemFit®: How to create a renal vascular system in vitro [INTERVIEW]

Zara Puckrin, BSc / 15 September 2020
Drug Discovery

What is translational research?

Zara Puckrin, BSc / 11 September 2020
Clinical Capabilities

StemFit: iPSCs for corneal epithelial stem cell deficiency [INTERVIEW]

Zara Puckrin, BSc / 4 September 2020
Drug Discovery

This light-activated treatment could help patients with peripheral artery disease [INTERVIEW]

Zara Puckrin, BSc / 1 September 2020

Subscribe to recieve updates
1 2 3 4 5 Next

Posts by Topic

© 2021 REPROCELL Inc. All rights reserved.

REPROCELL Inc.  日本語  MetLife Shin-yokohama 381, Bldg. 9F, 3-8-11 Shin-yokohama, Kohoku-ku, Yokohama, Kanagawa 222-0033, Japan

REPROCELL USA Inc. 9000 Virginia Manor Road, Suite 207, Beltsville, 20705, USA

REPROCELL Europe Ltd. Thomson Pavilion, Todd Campus, West of Scotland Science Park, Acre Road, Glasgow, G20 0XA, United Kingdom

Bioserve Biotechnologies (India) PVT Ltd. Unit: D4-D7, 1st Floor, Industrial Estate, Moula Ali, Medchal-Malkajgiri Dist., Hyderabad-500040, Telangana, India